Cargando…

Alternative Splicing of the Angiogenesis Associated Extra-Domain B of Fibronectin Regulates the Accessibility of the B-C Loop of the Type III Repeat 8

BACKGROUND: Fibronectin (FN) is a multi-domain molecule involved in many cellular processes, including tissue repair, embryogenesis, blood clotting, and cell migration/adhesion. The biological activities of FN are mediated by exposed loops located mainly at the interdomain interfaces that interact w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ventura, Elisa, Sassi, Francesca, Parodi, Arianna, Balza, Enrica, Borsi, Laura, Castellani, Patrizia, Carnemolla, Barbara, Zardi, Luciano
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818841/ https://www.ncbi.nlm.nih.gov/pubmed/20161770 http://dx.doi.org/10.1371/journal.pone.0009145

Ejemplares similares

Selective targeted delivery of the TNF-alpha receptor p75 and uteroglobin to the vasculature of inflamed tissues: a preliminary report
por: Ventura, Elisa, et al.
Publicado: (2011)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
por: Balza, Enrica, et al.
Publicado: (2006)

Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine
por: Mortara, Lorenzo, et al.
Publicado: (2013)

C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8
por: Ventura, Elisa, et al.
Publicado: (2016)

The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1
por: Serini, Guido, et al.
Publicado: (1998)

Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma
por: Kosmehl, H, et al.
Publicado: (1999)

Lack of Fibronectin Extra Domain A Alternative Splicing Exacerbates Endothelial Dysfunction in Diabetes
por: Gortan Cappellari, Gianluca, et al.
Publicado: (2016)

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer
por: Lieverse, Relinde I. Y., et al.
Publicado: (2020)

CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B
por: Zhang, Zhijie, et al.
Publicado: (2022)

Anti-Extra Domain B Splice Variant of Fibronectin Antibody–Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade
por: Hooper, Andrea T., et al.
Publicado: (2022)

Splicing fibronectin's functions
por: Dove, Alan W.
Publicado: (2003)

Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
por: Mortara, Lorenzo, et al.
Publicado: (2018)

Use of the Uteroglobin Platform for the Expression of a Bivalent Antibody against Oncofetal Fibronectin in Escherichia coli
por: Ventura, Elisa, et al.
Publicado: (2013)

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts
por: Orecchia, Paola, et al.
Publicado: (2015)

MRI of Breast Tumor Initiating Cells Using the Extra Domain-B of Fibronectin Targeting Nanoparticles
por: Sun, Yujin, et al.
Publicado: (2014)

Expression of Fibronectin Isoforms in Human Breast Tissue: Production of Extra Domain A(+)/Extra Domain B(+) by Cancer Cells and Extra Domain A(+) by Stromal Cells
por: Matsumoto, Ei‐ichi, et al.
Publicado: (1999)

Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma
por: Balza, Enrica, et al.
Publicado: (2017)

Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin
por: Zhang, Zhijie, et al.
Publicado: (2023)

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
por: Orecchia, Paola, et al.
Publicado: (2019)

Fibronectin containing alternatively spliced extra domain A interacts at the central and c-terminal domain of Toll-like receptor-4
por: Gupta, Shubhangi, et al.
Publicado: (2022)

Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models
por: Balza, Enrica, et al.
Publicado: (2021)

Selective secretion of alternatively spliced fibronectin variants
Publicado: (1989)

Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma
por: Saw, Phei Er, et al.
Publicado: (2021)

Fibronectin extra domain a limits liver dysfunction and protects mice during acute inflammation()
por: Venu, Vivek Krishna Pulakazhi, et al.
Publicado: (2023)

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models
por: El-Emir, E, et al.
Publicado: (2007)

Retroviral expression of alternatively spliced forms of rat fibronectin
Publicado: (1990)

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
por: Martín-Otal, Celia, et al.
Publicado: (2022)

Tumor Angiogenesis in the Absence of Fibronectin or Its Cognate Integrin Receptors
por: Murphy, Patrick A., et al.
Publicado: (2015)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy
por: Sackey-Aboagye, Bridget, et al.
Publicado: (2016)

Correction: Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Publicado: (2022)

Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance
por: Mirzaei, Akram, et al.
Publicado: (2018)

Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery
por: Yu, Mikyung, et al.
Publicado: (2018)

Fibronectin-binding protein B variation in Staphylococcus aureus
por: Burke, Fiona M, et al.
Publicado: (2010)

Modulation of Cell-adhesive Activity of Fibronectin by the Alternatively Spliced EDA Segment
por: Manabe, Ri-ichiroh, et al.
Publicado: (1997)

Identification and functional characterization of imbalanced osteoarthritis-associated fibronectin splice variants
por: van Hoolwerff, Marcella, et al.
Publicado: (2022)

TLR3 agonists induce fibronectin aggregation by activated astrocytes: a role of pro-inflammatory cytokines and fibronectin splice variants
por: Werkman, Inge, et al.
Publicado: (2020)

A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis
por: Pradella, Davide, et al.
Publicado: (2021)

Functional importance of Crenarchaea-specific extra-loop revealed by an X-ray structure of a heterotetrameric crenarchaeal splicing endonuclease
por: Yoshinari, Shigeo, et al.
Publicado: (2009)

Thrombomodulin promotes focal adhesion kinase activation and contributes to angiogenesis by binding to fibronectin
por: Hsu, Yun-Yan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v6v14gb5nm7vlht2hmo42n2fa0